UECG vs. LABU

Last updated Jul 12, 2026

UECG (Leverage Shares 2X Long UEC Daily ETF) and LABU (Direxion Daily S&P Biotech Bull 3x Shares) are both Leveraged Equities funds - UECG tracks the Uranium Energy Corp. (UEC) while LABU tracks the S&P Biotechnology Select Industry Index (300%). Both are passively managed. At a 0.39 correlation, their price movements are largely independent. UECG charges 0.75%/yr vs 0.96%/yr for LABU.

Performance

UECG vs. LABU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Leverage Shares 2X Long UEC Daily ETF (UECG) and Direxion Daily S&P Biotech Bull 3x Shares (LABU). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

UECG

• 1D: 7.11%
• 1M: -11.46%
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

LABU

• 1D: -9.38%
• 1M: 64.51%
• 6M: 75.19%
• YTD: 84.35%
• 1Y: 354.66%
• 3Y*: 35.47%
• 5Y*: -26.65%
• 10Y*: -7.90%

*Multi-year figures are annualized to reflect compound growth (CAGR)

UECG vs. LABU - Yearly Performance Comparison

	2026 (YTD)
UECG Leverage Shares 2X Long UEC Daily ETF	-73.13%
LABU Direxion Daily S&P Biotech Bull 3x Shares	73.68%

Correlation

The correlation between UECG and LABU is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Feb 10, 2026	0.39

Return for Risk

UECG vs. LABU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UECG

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

LABU

LABU Risk / Return Rank: 95
LABU Sharpe Ratio Rank: 98
LABU Sortino Ratio Rank: 93
LABU Omega Ratio Rank: 89
LABU Calmar Ratio Rank: 98
LABU Martin Ratio Rank: 97

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UECG vs. LABU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Leverage Shares 2X Long UEC Daily ETF (UECG) and Direxion Daily S&P Biotech Bull 3x Shares (LABU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	UECG	LABU	Difference
Sharpe ratio: Return per unit of total volatility	—	4.25	—
Sortino ratio: Return per unit of downside risk	—	3.67	—
Omega ratio: Gain probability vs. loss probability	—	1.44	—
Calmar ratio: Return relative to maximum drawdown	—	10.97	—
Martin ratio: Return relative to average drawdown	—	30.90	—

Drawdowns

UECG vs. LABU - Drawdown Comparison

The maximum UECG drawdown since its inception was -77.37%, smaller than the maximum LABU drawdown of -99.18%. Use the drawdown chart below to compare losses from any high point for UECG and LABU.

Drawdown Indicators

	UECG	LABU	Difference
Max Drawdown Largest peak-to-trough decline	-77.37%	-99.18%	+21.81%
Max Drawdown (1Y) Largest decline over 1 year	—	-30.70%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-78.30%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-97.36%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-98.96%	—
Current Drawdown Current decline from peak	-73.13%	-93.50%	+20.37%
Average Drawdown Average peak-to-trough decline	-43.17%	-81.77%	+38.60%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	10.92%	—

Volatility

Volatility by Period

	UECG	LABU	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	23.42%	—
Volatility (6M) Calculated over the trailing 6-month period	—	63.16%	—
Volatility (1Y) Calculated over the trailing 1-year period	159.78%	79.22%	+80.56%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	159.78%	96.01%	+63.77%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	159.78%	95.21%	+64.57%

UECG vs. LABU - Expense Ratio Comparison

UECG has a 0.75% expense ratio, which is lower than LABU's 0.96% expense ratio.

Dividends

UECG vs. LABU - Dividend Comparison

UECG has not paid dividends to shareholders, while LABU's dividend yield for the trailing twelve months is around 0.34%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
LABU Direxion Daily S&P Biotech Bull 3x Shares	0.34%	0.84%	0.35%	0.35%	0.00%	0.00%	0.00%	0.28%	0.64%	0.17%
UECG Leverage Shares 2X Long UEC Daily ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both UECG and LABU in my portfolio?

UECG and LABU have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, UECG or LABU?

On fees, UECG is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, UECG or LABU?

UECG is cheaper with a 0.75% expense ratio, compared with 0.96% for LABU.

Which ETF pays a higher dividend yield, UECG or LABU?

LABU has the higher dividend yield at 0.34%, compared with 0.00% for UECG.

What is the main difference between UECG and LABU?

UECG tracks Uranium Energy Corp. (UEC), while LABU tracks S&P Biotechnology Select Industry Index (300%). They also come from different issuers: Leverage Shares and Direxion. Their fees differ too: 0.75% for UECG and 0.96% for LABU.